"Mastocytosis, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
Concept/Terms
Mastocytosis, Systemic- Mastocytosis, Systemic
- Mastocytoses, Systemic
- Systemic Mastocytoses
- Systemic Mastocytosis
- Systemic Mast-Cell Disease
- Mast-Cell Disease, Systemic
- Mast-Cell Diseases, Systemic
- Systemic Mast Cell Disease
- Systemic Mast-Cell Diseases
Indolent Systemic Mastocytosis- Indolent Systemic Mastocytosis
- Indolent Systemic Mastocytoses
- Mastocytoses, Indolent Systemic
- Mastocytosis, Indolent Systemic
- Systemic Mastocytoses, Indolent
- Systemic Mastocytosis, Indolent
Aggressive Systemic Mastocytosis- Aggressive Systemic Mastocytosis
- Aggressive Systemic Mastocytoses
- Mastocytoses, Aggressive Systemic
- Mastocytosis, Aggressive Systemic
- Systemic Mastocytoses, Aggressive
- Systemic Mastocytosis, Aggressive
Below are MeSH descriptors whose meaning is more general than "Mastocytosis, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Mastocytosis, Systemic".
This graph shows the total number of publications written about "Mastocytosis, Systemic" by people in Harvard Catalyst Profiles by year, and whether "Mastocytosis, Systemic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 0 | 3 |
| 2014 | 5 | 0 | 5 |
| 2015 | 4 | 1 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 6 | 0 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 7 | 0 | 7 |
| 2022 | 12 | 0 | 12 |
| 2023 | 4 | 0 | 4 |
Below are the most recent publications written about "Mastocytosis, Systemic" by people in Profiles.
-
A Review of the Clinical Features and Management of Systemic Congenital Mastocytosis through the Presentation of An Unusual Prenatal-Onset Case. Curr Oncol. 2023 10 03; 30(10):8992-9003.
-
Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Ann Allergy Asthma Immunol. 2023 11; 131(5):668-670.
-
The international consensus classification of eosinophilic disorders and systemic mastocytosis. Am J Hematol. 2023 08; 98(8):1286-1306.
-
Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evid. 2023 Jun; 2(6):EVIDoa2200339.
-
Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis. Blood Adv. 2022 11 08; 6(21):5750-5762.
-
Disease correlates and clinical relevance of hereditary a-tryptasemia in patients with systemic mastocytosis. J Allergy Clin Immunol. 2023 02; 151(2):485-493.e11.
-
Avapritinib for advanced systemic mastocytosis. Blood. 2022 10 13; 140(15):1667-1673.
-
MPN-435 Overall Survival in Patients With Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy. Clin Lymphoma Myeloma Leuk. 2022 Oct; 22 Suppl 2:S337.
-
Towards personalized medicine with iPS cell technology: a case report of advanced systemic mastocytosis with associated eosinophilia. Ann Hematol. 2022 11; 101(11):2533-2536.
-
Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey. Cancer. 2022 10; 128(20):3700-3708.